Federal funding analysis
Reported transaction obligations
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 12 of 12 selected awards have dated, valued transactions.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $1.2M |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $2.4M |
| Change | $-1.2M |
| Growth | -50.2%Why this funding changeNet obligations in equal-length adjacent periods. ($1,198,105.24 − $2,404,969.67) ÷ $2,404,969.67 × 100 = -50.18%
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Negative obligation adjustments can produce a decline below −100%. |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Defense | $3.9M | 11 |
| Department of Health and Human Services | $-59 | 1 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| W40M USA HCA | $2.3M | 5 |
| W40M MRCO EAST | $1.5M | 5 |
| GPC COMPONENT PROGRAM MANAGER | $24.6K | 1 |
| NATIONAL INSTITUTES OF HEALTH - CC | $-59 | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325414 — Biological Product (except Diagnostic) Manufacturing | $3.0M | 6 |
| 325412 — Pharmaceutical Preparation Manufacturing | $884.6K | 6 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets | $3.6M | 9 |
| 6505 — Drugs and Biologicals | $285.2K | 3 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| W91YTZ25DA003 | $1.8M | 2 |
| W81K0425DA010 | $1.2M | 4 |
| W91YTZ24D0004 | $599.4K | 3 |
| W81K0423D0004 | $260.7K | 1 |
| V797D50589 | $24.6K | 1 |
| Unclassified | $-59 | 1 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $3.9M | 11 |
| NO SET ASIDE USED. | $-59 | 1 |